Answer: Prestudy site visit
Most relevant text from all around the web:
Which monitoring visit would not include an inventory of investigational agents?
The FDA requires retention of investigational drug study records for: At least two years after the investigational drug's approval by the FDA . Which monitoring visit would NOT include an inventory of investigational agents?
Fri May 25 2018 · Answer. 21 CFR 812 Investigational Device Exemptions would not include an inventory of investigational agents . It is a tool that's the topic of a clinical study to be utilized in order to gather safety and effectiveness information needed to support a pre-market approval (PMA) application or a pre-market notification.
Subject 311 has had elevated white blood cell (WBC ) counts for the past two (2) study visits with no clinical signs or symptoms. " Increased WBC count " is not listed in the Investigator's Brochure (IB) as an adverse event. A systematic and independent examination of trial-related...
Disclaimer:
Our tool is still learning and trying its best to find the correct answer to your question. Now its your turn, "The more we share The more we have". Comment any other details to improve the description, we will update answer while you visit us next time...Kindly check our comments section, Sometimes our tool may wrong but not our users.
Are We Wrong To Think We're Right? Then Give Right Answer Below As Comment
Report the elevated WBC to the sponsor as an unexpected adverse event
ReplyDelete